241 related articles for article (PubMed ID: 9623513)
1. Predominant implication of IL-5 in acute eosinophilic pneumonia: comparison with chronic eosinophilic pneumonia.
Okubo Y; Horie S; Hachiya T; Momose T; Tsukadaira A; Takashi S; Suzuki J; Isobe M; Sekiguchi M
Int Arch Allergy Immunol; 1998 May; 116(1):76-80. PubMed ID: 9623513
[TBL] [Abstract][Full Text] [Related]
2. Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.
Katoh S; Ikeda M; Matsumoto N; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Nakazato M; Oka M
Lung; 2017 Dec; 195(6):707-712. PubMed ID: 28875265
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia.
Nakahara Y; Hayashi S; Fukuno Y; Kawashima M; Yatsunami J
Respiration; 2001; 68(4):389-95. PubMed ID: 11464086
[TBL] [Abstract][Full Text] [Related]
4. Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia.
Katoh S; Nobumoto A; Matsumoto N; Matsumoto K; Ehara N; Niki T; Inada H; Nishi N; Yamauchi A; Fukushima K; Hirashima M
Int Arch Allergy Immunol; 2010; 153(3):294-302. PubMed ID: 20484929
[TBL] [Abstract][Full Text] [Related]
5. IL-5 predominant in bronchoalveolar lavage fluid and peripheral blood in a patient with acute eosinophilic pneumonia.
Yamaguchi S; Okubo Y; Hossain M; Fujimoto K; Honda T; Kubo K; Sekiguchi M; Takatsu K
Intern Med; 1995 Jan; 34(1):65-8. PubMed ID: 7718986
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of antimicrobial peptides in bronchoalveolar lavage fluid in patients with chronic eosinophilic pneumonia.
Ashitani J; Matsumoto N; Nakazato M
Respiration; 2007; 74(1):69-75. PubMed ID: 16369124
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of interleukin 33 (IL-33) in patients with eosinophilic pneumonia.
Mato N; Bando M; Kusano A; Hirano T; Nakayama M; Uto T; Nakaya T; Yamasawa H; Sugiyama Y
Allergol Int; 2013 Mar; 62(1):45-52. PubMed ID: 23000728
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia.
Fujimura M; Yasui M; Shinagawa S; Nomura M; Matsuda T
Respir Med; 1998 May; 92(5):743-9. PubMed ID: 9713634
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil transendothelial migration induced by the bronchoalveolar lavage fluid of acute eosinophilic pneumonia.
Nakagome K; Shoda H; Shirai T; Nishihara F; Soma T; Uchida Y; Sakamoto Y; Nagata M
Respirology; 2017 Jul; 22(5):913-921. PubMed ID: 28139852
[TBL] [Abstract][Full Text] [Related]
10. A specific elevation of RANTES in bronchoalveolar lavage fluids of patients with chronic eosinophilic pneumonia.
Kurashima K; Mukaida N; Fujimura M; Yasui M; Shinagawa T; Matsuda T; Ohmoto Y; Matsushima K
Lab Invest; 1997 Jan; 76(1):67-75. PubMed ID: 9010450
[TBL] [Abstract][Full Text] [Related]
11. Elevated Periostin Concentrations in the Bronchoalveolar Lavage Fluid of Patients with Eosinophilic Pneumonia.
Nakagome K; Nakamura Y; Kobayashi T; Ohta S; Ono J; Kobayashi K; Ikebuchi K; Noguchi T; Soma T; Yamauchi K; Izuhara K; Nagata M
Int Arch Allergy Immunol; 2019; 178(3):264-271. PubMed ID: 30612125
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of acute eosinophilic inflammation in a case of acute eosinophilic pneumonia in a 14-year-old girl.
Godding V; Bodart E; Delos M; Sibille Y; Galanti L; De Coster P; Jarjour N; Busse WW
Clin Exp Allergy; 1998 Apr; 28(4):504-9. PubMed ID: 9641579
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease.
Taniguchi H; Katoh S; Kadota J; Matsubara Y; Fukushima K; Mukae H; Matsukura S; Kohno S
Eur Respir J; 2000 Nov; 16(5):959-64. PubMed ID: 11153599
[TBL] [Abstract][Full Text] [Related]
15. Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry.
Matsuno O; Ono E; Ueno T; Takenaka R; Nishitake T; Hiroshige S; Miyazaki E; Kumamoto T; Higuchi Y
Respir Med; 2010 Jan; 104(1):34-9. PubMed ID: 19625177
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production at the site of disease in chronic eosinophilic pneumonitis.
Kita H; Sur S; Hunt LW; Edell ES; Weiler DA; Swanson MC; Samsel RW; Abrams JS; Gleich GJ
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1437-41. PubMed ID: 8616578
[TBL] [Abstract][Full Text] [Related]
17. Tobacco smoking associated with the increases of the bronchoalveolar levels of interleukin-5 and interleukin-1 receptor antagonist in acute eosinophilic pneumonia.
Teng Y; Gao Y
Eur Rev Med Pharmacol Sci; 2014; 18(6):887-93. PubMed ID: 24706315
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced eosinophilic pneumonia: A review of 196 case reports.
Bartal C; Sagy I; Barski L
Medicine (Baltimore); 2018 Jan; 97(4):e9688. PubMed ID: 29369189
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of acute eosinophilic pneumonia--analyses of cytokines in BALF before and after treatment].
Fujiuchi S; Yamazaki Y; Matsumoto H; Fujita Y; Okamoto K; Fujiwara K; Toyoshima E; Takahashi M; Sato K; Takeda A; Fujikane T; Tobise K
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):60-5. PubMed ID: 11296389
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of correlation between peripheral eosinophil count and serum levels of IL-5 and tryptase in acute eosinophilic pneumonia.
Jhun BW; Kim SJ; Kim K; Lee JE; Hong DJ
Respir Med; 2014 Nov; 108(11):1655-62. PubMed ID: 25301289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
